Back to Search Start Over

Fibroblast Growth Factor-2 Is an Important Factor that Maintains Cellular Immaturity and Contributes to Aggressiveness of Osteosarcoma

Authors :
Hiroshi Nishio
Takatsune Shimizu
Yumi Matsuzaki
Hajime Mori
Shinji Kuninaka
Hiroshi Ijiri
Eiji Sugihara
Takeshi Miyamoto
Arisa Ueki
Yoshiaki Toyama
Yasuo Ikeda
Tomoki Ishikawa
Tomonori Yaguchi
Hideyuki Saya
Yutaka Kawakami
Nobuyuki Onishi
Sayaka Iwai
Source :
Molecular Cancer Research. 10:454-468
Publication Year :
2012
Publisher :
American Association for Cancer Research (AACR), 2012.

Abstract

Osteosarcoma is the most frequent, nonhematopoietic, primary malignant tumor of bone. Histopathologically, osteosarcoma is characterized by complex mixtures of different cell types with bone formation. The role of environmental factors in the formation of such a complicated tissue structure as osteosarcoma remains to be elucidated. Here, a newly established murine osteosarcoma model was used to clarify the roles of environmental factors such as fibroblast growth factor-2 (Fgf2) or leukemia-inhibitory factor (Lif) in the maintenance of osteosarcoma cells in an immature state. These factors were highly expressed in tumor environmental stromal cells, rather than in osteosarcoma cells, and they potently suppressed osteogenic differentiation of osteosarcoma cells in vitro and in vivo. Further investigation revealed that the hyperactivation of extracellular signal–regulated kinase (Erk)1/2 induced by these factors affected in the process of osteosarcoma differentiation. In addition, Fgf2 enhanced both proliferation and migratory activity of osteosarcoma cells and modulated the sensitivity of cells to an anticancer drug. The results of the present study suggest that the histology of osteosarcoma tumors which consist of immature tumor cells and pathologic bone formations could be generated dependent on the distribution of such environmental factors. The combined blockade of the signaling pathways of several growth factors, including Fgf2, might be useful in controlling the aggressiveness of osteosarcoma. Mol Cancer Res; 10(3); 454–68. ©2012 AACR.

Details

ISSN :
15573125 and 15417786
Volume :
10
Database :
OpenAIRE
Journal :
Molecular Cancer Research
Accession number :
edsair.doi.dedup.....c88788db4f52e561931c9144aa6bfc7b
Full Text :
https://doi.org/10.1158/1541-7786.mcr-11-0347